+1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

Case ReportOpen Access

Invasive Cystic Hypersecretory Carcinoma of Breast: A Case Report

Volume 2 - Issue 2

Yao Yongzhong*1,2, Shi Xianbiao1, Zhao Yixin2, You Xin2, Wang Jingmei3, Yu Huiping3 and Wang Shouju*4

  • Author Information Open or Close
    • 1Department of Breast Surgery, Medical School of Nanjing University, Nanjing, China
    • 2Department of Surgery, Southeast University, Nanjing, China
    • 3Department of Pathology, Medical School of Nanjing University, Nanjing, China
    • 4Department of Medical Imaging, Nanjing University, Nanjing, China

    *Corresponding author: Wang Shouju, Department of Medical Imaging, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, 210000, China

Received: January 23, 2018;   Published: February 02, 2018

DOI: 10.26717/BJSTR.2018.02.000720

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF


Invasive cystic hypersecretory hyperplasia (CHH) of the breast is very rare. The clinical manifestation of CHH iscystic masses, and it is not easy to determine its biological characteristics before an operation. A 54-year-old female patient was admitted with a cystic massin the left breastfor one week. After the operation, the pathology diagnosis was invasive CHC, and the postoperative period was uneventful.

Keywords: Invasive Cystic Hypersecretory Carcinoma (Chc); Breast Cancer; Breast-Conserving Surgery; Palpable Mass

Abbreviation: CHH: Cystic Hypersecretory Hyperplasia; CHC: Cystic Hypersecretory Carcinoma; TG: Thyro Globulin; TTF-1: Thyroid Transcription Factor-1; GATA3: GATA binding protein 3; ER: Estrogen Receptor; PR: Progesterone Receptor; HER-2: Human Epidermal growth factor Receptor-2

Abstract| Introduction| Case Report| Discussion| Acknowledgement| References|